MedPath

Mupirocin

These highlights do not include all the information needed to use MUPIROCIN OINTMENT safely and effectively. See full prescribing information for MUPIROCIN OINTMENT. MUPIROCIN ointment, for topical use Initial U.S. Approval: 1987

Approved
Approval ID

6d59e35c-b262-7940-e053-2991aa0a8908

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 10, 2019

Manufacturers
FDA

Lohxa

DUNS: 079872715

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mupirocin

PRODUCT DETAILS

NDC Product Code70166-355
Application NumberANDA065170
Marketing CategoryC73584
Route of AdministrationTOPICAL
Effective DateSeptember 10, 2019
Generic NameMupirocin

INGREDIENTS (3)

POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
POLYETHYLENE GLYCOL 3350Inactive
Code: G2M7P15E5P
Classification: IACT
MUPIROCINActive
Quantity: 20 mg in 1 g
Code: D0GX863OA5
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mupirocin - FDA Drug Approval Details